A Study in Relapse Prevention of Treatment-Resistant Depression

NCT00958568 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

892

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Depression

Interventions

DRUG: Olanzapine and Fluoxetine combination (OFC)
DRUG: Fluoxetine

Sponsor

Eli Lilly and Company